Hawkins (NASDAQ:HWKN) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen cut shares of Hawkins (NASDAQ:HWKN) from a buy rating to a hold rating in a report issued on Saturday.

HWKN has been the subject of several other reports. BWS Financial restated a “buy” rating and issued a $160.00 target price on shares of Hawkins in a report on Thursday, May 15th. CJS Securities began coverage on Hawkins in a report on Tuesday, April 1st. They issued a “market outperform” rating and a $125.00 target price for the company.

Hawkins Trading Up 1.2%

Shares of NASDAQ HWKN opened at $152.43 on Friday. The stock has a market cap of $3.18 billion, a price-to-earnings ratio of 37.73, a PEG ratio of 2.55 and a beta of 0.85. The business has a 50 day simple moving average of $131.69 and a 200 day simple moving average of $119.31. Hawkins has a 52 week low of $89.59 and a 52 week high of $153.05. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.37 and a current ratio of 2.15.

Hawkins (NASDAQ:HWKN) last announced its quarterly earnings results on Wednesday, May 14th. The specialty chemicals company reported $0.78 EPS for the quarter, beating the consensus estimate of $0.74 by $0.04. The business had revenue of $245.32 million during the quarter, compared to analysts’ expectations of $230.69 million. Hawkins had a return on equity of 18.93% and a net margin of 8.66%. On average, research analysts predict that Hawkins will post 4 earnings per share for the current fiscal year.

Hawkins Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 30th were issued a $0.18 dividend. The ex-dividend date of this dividend was Friday, May 30th. This represents a $0.72 annualized dividend and a yield of 0.47%. Hawkins’s dividend payout ratio (DPR) is currently 17.82%.

Institutional Investors Weigh In On Hawkins

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Brooklyn Investment Group lifted its holdings in Hawkins by 533.3% in the 1st quarter. Brooklyn Investment Group now owns 266 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 224 shares during the last quarter. Vermillion Wealth Management Inc. acquired a new stake in Hawkins in the 4th quarter worth approximately $34,000. Whittier Trust Co. of Nevada Inc. lifted its holdings in Hawkins by 118.8% in the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 280 shares of the specialty chemicals company’s stock worth $30,000 after purchasing an additional 152 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Hawkins in the 1st quarter worth approximately $42,000. Finally, NewEdge Advisors LLC bought a new position in Hawkins in the 4th quarter worth approximately $53,000. 69.71% of the stock is currently owned by institutional investors and hedge funds.

Hawkins Company Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.